HE4--a novel promising serum marker in the diagnosis of ovarian carcinoma
Biomarkers have a wide range of applications in the management of several cancers. To date serum markers have been the most extensively used biomarkers in everyday practice but few markers are elevated in preclinical or premalignant disease, limiting their importance for estimating risk or for scree...
Saved in:
Published in | European journal of gynaecological oncology Vol. 32; no. 6; p. 605 |
---|---|
Main Authors | , , , , , |
Format | Journal Article |
Language | English |
Published |
Italy
2011
|
Subjects | |
Online Access | Get more information |
Cover
Loading…
Abstract | Biomarkers have a wide range of applications in the management of several cancers. To date serum markers have been the most extensively used biomarkers in everyday practice but few markers are elevated in preclinical or premalignant disease, limiting their importance for estimating risk or for screening. Human epididymis protein-4 (HE4) is a novel serum marker which is more sensitive in the prediction of risk of ovarian malignancy than CA125 alone in patients with a pelvic mass. HE4 in combination with CA125 appears to be an effective tool for the early detection of recurrence or monitoring the response to therapy. Risk of Ovarian Malignancy Algorithm, utilizing the dual marker combination of HE4 and CA125, can be used to stratify both postmenopausal and premenopausal women into high- and low-risk groups, allowing for an effective triage of women to appropriate institutions for their care. A review of HE4 and its feasibility as a novel diagnostic tool in the management of epithelial ovarian cancer is presented. |
---|---|
AbstractList | Biomarkers have a wide range of applications in the management of several cancers. To date serum markers have been the most extensively used biomarkers in everyday practice but few markers are elevated in preclinical or premalignant disease, limiting their importance for estimating risk or for screening. Human epididymis protein-4 (HE4) is a novel serum marker which is more sensitive in the prediction of risk of ovarian malignancy than CA125 alone in patients with a pelvic mass. HE4 in combination with CA125 appears to be an effective tool for the early detection of recurrence or monitoring the response to therapy. Risk of Ovarian Malignancy Algorithm, utilizing the dual marker combination of HE4 and CA125, can be used to stratify both postmenopausal and premenopausal women into high- and low-risk groups, allowing for an effective triage of women to appropriate institutions for their care. A review of HE4 and its feasibility as a novel diagnostic tool in the management of epithelial ovarian cancer is presented. |
Author | Langmár, Z Németh, M Király, M Hornyák, L Vleskó, G Bösze, P |
Author_xml | – sequence: 1 givenname: Z surname: Langmár fullname: Langmár, Z email: langmarzoltan@hotmail.com organization: 2nd Department of Obstetrics and Gynecology, Semmelweis University, Budapest, Hungary. langmarzoltan@hotmail.com – sequence: 2 givenname: M surname: Németh fullname: Németh, M – sequence: 3 givenname: G surname: Vleskó fullname: Vleskó, G – sequence: 4 givenname: M surname: Király fullname: Király, M – sequence: 5 givenname: L surname: Hornyák fullname: Hornyák, L – sequence: 6 givenname: P surname: Bösze fullname: Bösze, P |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/22335019$$D View this record in MEDLINE/PubMed |
BookMark | eNo1j8tqAjEUQLOw1Ef9hZIfCCQ3mcxkWcRWQXDTruVOHprWSYZEhf59hbarszucMyeTlJOfkBmXBhgYqadkXusn50q1Gh7JFEDKhgszI9vNWjGGNOWbP9Ox5CHWmI60-nId6IDlyxcaE72cPHURjynXWGkONN-wREzUYrEx5QGfyEPAc_XLPy7Ix-v6fbVhu_3bdvWyYyMIfmEYjPDcaaUCADdd67jlplHintT1AnxjtXdWaSlD09kmCGx96BwKpbreaFiQ51_veO0H7w5jiffM78P_E_wAW9xIMw |
ContentType | Journal Article |
DBID | CGR CUY CVF ECM EIF NPM |
DatabaseName | Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed |
DatabaseTitle | MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) |
DatabaseTitleList | MEDLINE |
Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database |
DeliveryMethod | no_fulltext_linktorsrc |
ExternalDocumentID | 22335019 |
Genre | Journal Article Review |
GroupedDBID | --- 53G 5GY 5RE ABDBF ABOCM ADCBC AENEX ALMA_UNASSIGNED_HOLDINGS CGR CUY CVF EBS ECM EIF EJD F5P NPM OK1 UDS W2D |
ID | FETCH-LOGICAL-p210t-af91e0d644f220987d0c095412338b12e5c6edc4633f58c5f1a7ef8da1448b962 |
ISSN | 0392-2936 |
IngestDate | Thu May 23 23:49:10 EDT 2024 |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 6 |
Language | English |
LinkModel | OpenURL |
MergedId | FETCHMERGED-LOGICAL-p210t-af91e0d644f220987d0c095412338b12e5c6edc4633f58c5f1a7ef8da1448b962 |
PMID | 22335019 |
ParticipantIDs | pubmed_primary_22335019 |
PublicationCentury | 2000 |
PublicationDate | 2011-00-00 |
PublicationDateYYYYMMDD | 2011-01-01 |
PublicationDate_xml | – year: 2011 text: 2011-00-00 |
PublicationDecade | 2010 |
PublicationPlace | Italy |
PublicationPlace_xml | – name: Italy |
PublicationTitle | European journal of gynaecological oncology |
PublicationTitleAlternate | Eur J Gynaecol Oncol |
PublicationYear | 2011 |
SSID | ssj0044762 |
Score | 2.0168304 |
SecondaryResourceType | review_article |
Snippet | Biomarkers have a wide range of applications in the management of several cancers. To date serum markers have been the most extensively used biomarkers in... |
SourceID | pubmed |
SourceType | Index Database |
StartPage | 605 |
SubjectTerms | Biomarkers, Tumor - blood CA-125 Antigen - blood Carcinoma, Ovarian Epithelial Female Humans Neoplasms, Glandular and Epithelial - diagnosis Ovarian Neoplasms - blood Ovarian Neoplasms - diagnosis Ovarian Neoplasms - etiology Ovarian Neoplasms - therapy Proteins - analysis Risk |
Title | HE4--a novel promising serum marker in the diagnosis of ovarian carcinoma |
URI | https://www.ncbi.nlm.nih.gov/pubmed/22335019 |
Volume | 32 |
hasFullText | |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnZ1JS8QwFMeDy8WLKO4bOXgbIl3StD2qKKOop1G8SVYRnXQYxwH99L4knc6C4nIppSml7Y--_t-WIHSYKmM4NYKAj5wQmuScFMwoEkkOWo5mUieu3_n6hrVv6eV9dj_Rce26SwbiSH582VfyH6pwDLi6Ltk_kG0uCgdgH_jCFgjD9leM22eUEN6y1VC_uEorYObDA7r_1m11XeFNf1THqEJJXZh9pBqChwwftnQLCdmqNs1fxedrrfr4brmWjZ2srJyKxl9x-9j1Kfe4P53tCHl4t0z1VOT17kW_Pruxk9QH5seVACFzH4f1r68nYxK-M28Uk6h7scqEgJBgk3Z2HMecMZrMN14PJoD1up4YSBeX9yx_Hp2ZM3s0NI_m88LZvRsXwwn_Z0pzFnJL9T26-aDr82d8C68xOitouXYO8HEgvYrmtF1DF4Ey9pRxQxl7yjhQxk8WA2XcUMaVwTVl3FBeR7fnZ53TNqkXwCA98MQHhJsy1pECyWqSJCqLXEUSJDEFtZEWIk50JplWkrI0NVkhMxPzXJtCcfCSC1GyZAMt2MrqLYQlXEVEKmYqLyjnES-FEDqiQoDDCyJxG22GJ3_ohVlOHkbvZOfbkV20NIa_hxYNfFZ6HzTaQBz4V_4Js9Q7kg |
link.rule.ids | 786 |
linkProvider | National Library of Medicine |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=HE4--a+novel+promising+serum+marker+in+the+diagnosis+of+ovarian+carcinoma&rft.jtitle=European+journal+of+gynaecological+oncology&rft.au=Langm%C3%A1r%2C+Z&rft.au=N%C3%A9meth%2C+M&rft.au=Vlesk%C3%B3%2C+G&rft.au=Kir%C3%A1ly%2C+M&rft.date=2011-01-01&rft.issn=0392-2936&rft.volume=32&rft.issue=6&rft.spage=605&rft_id=info%3Apmid%2F22335019&rft_id=info%3Apmid%2F22335019&rft.externalDocID=22335019 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0392-2936&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0392-2936&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0392-2936&client=summon |